AdaptHealth Corp. (AHCO) shares soared 5.03% during intraday trading on Wednesday, marking a significant rebound in the stock's performance.
The surge follows positive analyst commentary from RBC Capital Markets, which suggested AdaptHealth shares appeared oversold after the company's Q4 results and 2026 outlook. RBC expressed optimism about the long-term value of AdaptHealth's new capitated contract and the potential for similar value-based care arrangements, noting the company's national scale and strong clinical outcomes appeal to payors.
RBC reiterated its outperform rating and $13 price target on AdaptHealth, highlighting that the company is taking appropriate measures to de-risk implementation of the new contract through infrastructure preparation including adding employees, buying vehicles, and acquiring equipment.